After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when ...

Consumers are urged to understand which GLP-1 medications are safe, approved, and legal after May 22 If you're one of the ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.

Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of the medication.

This study assessed nutrient intake in adults using GLP-1 receptor agonists (GLP-1RAs) and found widespread deficiencies in ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.

The companies are allegedly selling "research grade" GLP-1 weight loss drugs that are not FDA-approved, and are selling the products without a pharmacy license.